Sales Automation review
Persana logo

Persana review

Sunset AI prospecting platform: Persana joined Rox and should be treated as an archived review.

  • Sales Automation
  • AI Prospecting
  • Enrichment
  • Signals
  • Sequencing

Verdict

Use carefully

0Score

From

Sunset

Setup

Advanced

Best fit

Archived reference only

What is Persana?

Persana was an AI prospecting and enrichment platform with credits for email and phone enrichment, signals, and outbound workflow support.

The standalone product is no longer a normal active buying option. Vendor sources say Persana joined Rox, billing was suspended on 2026-04-01, and the platform sunset on 2026-05-02.

Who it's for

Archived reference for former Persana users and teams deciding whether to evaluate Rox or a current Persana alternative.

  • Startups
  • Scale-ups
  • SMBs
  • Mid-market
  • Enterprise

Key features

  • AI prospecting
  • Email enrichment
  • Phone enrichment
  • Signals
  • Data providers
  • CRM-style workflows
  • Unlimited users
  • Annual credit plans

Pricing

From Sunset · Not available

Persana

Unavailable

sunset 2026-05-02

  • Joined Rox
  • Billing suspended
  • Use archive/redirect treatment

Persana vendor sources say billing was suspended on 2026-04-01 and the platform sunset on 2026-05-02 after joining Rox.

Operator notes

Treat this review as an archived product record until the page is redirected, removed, or rebuilt around Rox.

Do not use old Persana pricing or plan claims as active buying guidance.

Watchouts

  • Persana sunset on 2026-05-02 after joining Rox
  • Current pricing is unsafe to publish as an active offer
  • Decide whether to archive, redirect, or replace with a Rox review

Frequently asked questions

Is Persana a Clay alternative?

Not as a current standalone buying option. Persana should be treated as an archived review after joining Rox and sunsetting on 2026-05-02.

Does Persana include phone enrichment?

Historical Persana plans included enrichment features, but current Persana pricing and feature claims should not be used as active buying guidance.